-
IOVA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Iovance Biotherapeutics (IOVA)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 170.54 mm | 170.54 mm | 170.54 mm | 170.54 mm | 170.54 mm | 170.54 mm |
Cash burn (monthly) | (no burn) | 10.49 mm | 29.69 mm | 37.20 mm | 1.50 mm | 24.57 mm |
Cash used (since last report) | n/a | 29.29 mm | 82.90 mm | 103.87 mm | 4.19 mm | 68.60 mm |
Cash remaining | n/a | 141.25 mm | 87.64 mm | 66.67 mm | 166.35 mm | 101.94 mm |
Runway (months of cash) | n/a | 13.5 | 3.0 | 1.8 | 110.8 | 4.1 |
13F holders | Current |
---|---|
Total holders | 282 |
Opened positions | 39 |
Closed positions | 55 |
Increased positions | 106 |
Reduced positions | 82 |
13F shares | Current |
---|---|
Total value | 2.08 tn |
Total shares | 263.93 mm |
Total puts | 1.68 mm |
Total calls | 3.77 mm |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
Quogue Capital | 30.00 mm | $360.90 mm |
Vanguard | 27.31 mm | $256.48 bn |
Perceptive Advisors | 26.62 mm | $249.94 bn |
MHR Fund Management | 24.00 mm | $225.33 bn |
BLK BlackRock | 21.48 mm | $201.73 bn |
STT State Street | 13.20 mm | $123.97 bn |
Soleus Capital Management | 8.53 mm | $80.08 bn |
Hood River Capital Management | 8.14 mm | $76.48 bn |
T. Rowe Price Investment Management | 5.86 mm | $55.04 mm |
Geode Capital Management | 5.65 mm | $53.05 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Dec 24 | Raj K. Puri | Common Stock | Payment of exercise | Dispose F | No | No | 7.84 | 3,759 | 29.47 k | 155,412 |
16 Dec 24 | Raj K. Puri | Common Stock | Option exercise | Acquire M | No | No | 0 | 8,334 | 0.00 | 159,171 |
16 Dec 24 | Raj K. Puri | RSU Common stock | Option exercise | Dispose M | No | No | 0 | 8,334 | 0.00 | 8,334 |
2 Dec 24 | Frederick G Vogt | Common Stock | Payment of exercise | Dispose F | No | No | 9.07 | 4,426 | 40.14 k | 210,236 |
2 Dec 24 | Frederick G Vogt | Common Stock | Option exercise | Acquire M | No | No | 0 | 10,417 | 0.00 | 214,662 |
2 Dec 24 | Frederick G Vogt | RSU Common stock | Option exercise | Dispose M | No | No | 0 | 10,417 | 0.00 | 52,087 |
2 Dec 24 | Bilinsky Igor | Common Stock | Payment of exercise | Dispose F | No | No | 9.07 | 1,784 | 16.18 k | 57,539 |
2 Dec 24 | Bilinsky Igor | Common Stock | Option exercise | Acquire M | No | No | 0 | 3,516 | 0.00 | 59,323 |
2 Dec 24 | Bilinsky Igor | RSU Common stock | Option exercise | Dispose M | No | No | 0 | 3,516 | 0.00 | 17,581 |
2 Dec 24 | Finckenstein Friedrich Graf | Common Stock | Payment of exercise | Dispose F | No | No | 9.07 | 1,982 | 17.98 k | 62,651 |